Primecure Medicines Private Limited
About Primecure Medicines Private Limited
Data last updated:
Primecure Medicines Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 18 October 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC226376. Its GSTIN is 07AAGCP4598M1ZN (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mahesh Anand and Sharat Latta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No T4 Plot No. 9 Sharda Chamber Blk – D Lsc Parshant Vihar Rohini, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.69 Lakh, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹1,809 (net margin 0.1%) and EBITDA of ₹3,480 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Primecure Medicines Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No T4 Plot No. 9 Sharda Chamber Blk – D Lsc Parshant Vihar Rohini, Delhi, India – 110085
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Primecure Medicines Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Primecure Medicines is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Primecure Medicines Private Limited, buy the company report.
Financials of Primecure Medicines Private Limited
FY 2025 filings availablePrimecure Medicines Private Limited reported revenue of ₹17.69 Lakh (up 44% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 44% growth in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,480 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,809 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Primecure Medicines Private Limited, buy the company report.
Board of directors of Primecure Medicines Private Limited
Primecure Medicines has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Anand | Director | 18 Oct 2011 | 15 Years 0 Months | Current |
| Sharat Latta | Director | 18 Oct 2011 | 15 Years 0 Months | Current |
| Vibha Yadav Latta | Director | 18 Oct 2011 | 15 Years 0 Months | Current |
| Veena Anand | Director | 18 Oct 2011 | 15 Years 0 Months | Current |
Peer comparison
Primecure Medicines Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pushpraj Technologies (OPC) Private Limited | ₹17.71 Lakh (FY 2019) | Kaisar Bagh, Uttar Pradesh, India | ||||
| Welcode Pharmaceuticals Private Limited | ₹17.71 Lakh (FY 2021) | 6.0% | Thane, Maharashtra, India | |||
| Kaka Traders Pvt. Ltd. | ₹17.7 Lakh (FY 2025) | -42.0% | Kolkata, West Bengal, India | |||
| Shri Krishna Sales Promotion Private Limited | ₹17.7 Lakh (FY 2025) | -13.0% | Kolkata, West Bengal, India | |||
| Takshila Finance and Leasing Company Private Limited | ₹17.69 Lakh (FY 2016) | -88.0% | Gurgaon, Haryana, India | |||
| Primecure Medicines Private Limitedthis company | ₹17.69 Lakh (FY 2025) | ₹1,809 | 0.1% | 44.0% | Delhi, India | |
| Ganga Hirise Private Limited | ₹17.69 Lakh (FY 2025) | -1.0% | Kolkata, West Bengal, India | |||
| Nabira Exports Private Limited | ₹17.69 Lakh (FY 2025) | 28.0% | Mumbai, Maharashtra, India | |||
| SNP Air Conditioning Private Limited | ₹17.69 Lakh (FY 2025) | 35.0% | Gandhinagar, Gujarat, India | |||
| Vipanil Pharmaceuticals Private Limited | ₹17.68 Lakh (FY 2025) | 4.0% | Delhi, India | |||
| Everfresh Agencies Private Limited | ₹17.68 Lakh (FY 2024) | -2.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Primecure Medicines Private Limited, buy the company report.
Auditor
Primecure Medicines Private Limited is audited by Deep Singhal & Associates Chartered Accountants for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deep Singhal & Associates Chartered Accountants | FY 2017 | 029213N |
Shareholding
The shareholding of Primecure Medicines Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Primecure Medicines Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Primecure Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Primecure Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Primecure Medicines has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCP4598M1ZN | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Primecure Medicines Private Limited, buy the company report.
Recent activity
Primecure Medicines Private Limited has 4 board changes on record since 2011: 4 appointments. The latest: Mahesh Anand was appointed as Director on 18 Oct 2011.
Frequently asked questions
Primecure Medicines is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 18 October 2011 (15+ years old) and is registered under CIN U24232DL2011PTC226376.
Primecure Medicines has 4 current directors:
- Mahesh Anand - Director
- Sharat Latta - Director
- Vibha Yadav Latta - Director
- Veena Anand - Director
The latest financial statements of Primecure Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Primecure Medicines is 07AAGCP4598M1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of Primecure Medicines is U24232DL2011PTC226376. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Primecure Medicines was incorporated on 18 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Primecure Medicines by revenue are Pushpraj Technologies (OPC) Private Limited, Welcode Pharmaceuticals Private Limited, Kaka Traders Pvt. Ltd, Shri Krishna Sales Promotion Private Limited, Takshila Finance and Leasing Company Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Mahesh Anand was appointed as Director on 18 Oct 2011. Sharat Latta was appointed as Director on 18 Oct 2011. Veena Anand was appointed as Director on 18 Oct 2011. Primecure Medicines has 4 board changes on record in total.
The registered office of Primecure Medicines is at Office No T4 Plot No. 9 Sharda Chamber Blk – D Lsc Parshant Vihar Rohini, Delhi, India – 110085.
Primecure Medicines operates in the trading industry, in the other wholesale segment.
The compliance status of Primecure Medicines is compliant as of 04 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
